CSIMarket Company Name, Ticker, Industry, else..
 
Mediwound Ltd   (NASDAQ: MDWD)
 
Price: $12.6100 $-0.05 -0.395%
Day's High: $12.949999809265137 Week Perf: -2.78 %
Day's Low: $ 12.56 30 Day Perf: -10.69 %
Volume (M): 167,022 52 Wk High: $ 20.30
Volume (M$): $ 0 52 Wk Avg: $16.67
Open: $12.67 52 Wk Low: $12.52



 Market Capitalization (Millions $) 143
 Shares Outstanding (Millions) 11
 Employees 7
 Revenues (TTM) (Millions $) 23
 Net Income (TTM) (Millions $) -37
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0

Business Description


MediWound Ltd is a biopharmaceutical company that specializes in developing and commercializing novel products for the treatment of severe burns and chronic wounds. Their flagship product, NexoBrid, is an enzymatic debridement agent that significantly reduces the need for surgical intervention in burn patients. It works by selectively removing dead tissues, allowing for faster healing and reduced scarring. MediWound also offers other wound care products, such as EscharEx for chronic wounds.


   Company Address: 42 Hayarkon Street Yavne 8122745
   Company Phone Number: 971-4100   Stock Exchange / Ticker: NASDAQ MDWD


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BCDA        7.55% 
BEAT   -2.69%    
PSTV   -0.83%    
UEEC   -2.56%    
VCEL   -5.67%    
• View Complete Report
   



Financing Agreement

MediWound Secures Additional U.S. Department of Defense Funding to Advance NexoBrid Development for the U.S. Army

Published Thu, Dec 28 2023 12:00 PM UTC

MediWound Awarded $6.7 Million to Advance NexoBrid as a Non-Surgical Field Care Solution; R&D Budget Increased to $14.4 Million
MediWound, a leading biopharmaceutical company specializing in innovative wound healing solutions, has recently been awarded an additional $6.7 million to advance the development of NexoBrid as a non-surgical field care solution. With this fund...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 6.33
Price to Sales (Expected) -
Price to Book 3.29
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.14
Working Capital Ratio 1.8
Leverage Ratio (MRQ) 0.98
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.23 $
Revenues (TTM) 1.99 $
Cash Flow (TTM) -
Cash 0.42 $
Book Value 3.84 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 3,238,143
Net Income per Employee (TTM) -5,313,857
Receivable Turnover Ratio (TTM) 9.18
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) 0.28

Profitability Ratios Current
Gross Margin (MRQ) 19.19 %
Operating Margin (MRQ) -148.98 %
Net Margin (MRQ) -140.8 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Mediwound Ltd's Segments





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.